Block Exemption Request Differentiates "Label" From "Labeling"
This article was originally published in The Tan Sheet
Executive Summary
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder complies with provisions of the FD&C Act that differentiate a product's "label" from product "labeling," the company says in a Dec. 22 letter to FDA.
You may also be interested in...
“Grandfathered” Category Of “Convenience-Size” OTCs Sought By GSK
FDA's rule partially delaying implementation of OTC labeling requirements for certain "convenience-size" drugs should be amended to include a category of "grandfathered" products, GlaxoSmithKline says in an Oct. 25 citizen petition
“Grandfathered” Category Of “Convenience-Size” OTCs Sought By GSK
FDA's rule partially delaying implementation of OTC labeling requirements for certain "convenience-size" drugs should be amended to include a category of "grandfathered" products, GlaxoSmithKline says in an Oct. 25 citizen petition
“Grandfathered” Category Of “Convenience-Size” OTCs Sought By GSK
FDA's rule partially delaying implementation of OTC labeling requirements for certain "convenience-size" drugs should be amended to include a category of "grandfathered" products, GlaxoSmithKline says in an Oct. 25 citizen petition